Telix Pharmaceuticals reported AUD477.35M in Sales Revenues for its fiscal semester ending in June of 2026.





Sales Change Date
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 86.5M 125.57M Jun/2026
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesoblast USD 63.9M 33.6M Jun/2026
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Pacific Edge NZD 5.56M 379K Jun/2026
Paradigm Biopharmaceuticals AUD 284.06K 292.06K Dec/2025
Polynovo AUD 79.52M 9.19M Jun/2026
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Ramsay Health Care AUD 9.24B 100M Dec/2026
ResMed USD 1.43B 8.6M Mar/2026
Sonic Healthcare AUD 5.42B 30M Jun/2026